CYP2D6 is a key drug-metabolizing enzyme, but its direct relevance to longevity is poorly supported by evidence. Some studies have explored associations between CYP2D6 polymorphisms and age-related diseases or lifespan, but results are inconsistent and often population-specific. The primary role of CYP2D6 is in the metabolism of many pharmaceuticals (e.g., antidepressants, beta-blockers) and some endogenous compounds. A genetic variant can affect drug response and toxicity, but not directly lifespan. Without robust, reproducible associations in large longevity cohorts, its utility for personal longevity guidance remains speculative. Caveat: No validated tests for longevity based on CYP2D6 exist. Evidence: unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-b6eae68e2440a0e359bbd290